Kairos Pharma KAPA
NYSE KAPA
$0.60 +0.02 (+2.71%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) Research & Development (2023 - 2025)

Updated

Kairos Pharma's Research & Development was $2.14 million in FY2025, up 415.7% from $414,000 in FY2024.

Analysis

Kairos Pharma (KAPA) Research & Development (2023 - 2025) Analysis & Trends

  • Per Business Quant data, Research & Development in earlier years was $414,000 in FY2024 (+404.9%) and $82,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 3.65 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.34 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.05 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 1.76 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.81 Bn
10 Kairos Pharma 10.86 Mn -1.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 496,000.00
Mar 31, 2025 493,000.00
Dec 31, 2024 172,000.00
Sep 30, 2024 14,000.00
Jun 30, 2024 63,000.00
Mar 31, 2024 165,000.00
Dec 31, 2023 7,000.00
Sep 30, 2023 33,000.00
API Access

Kairos Pharma Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=KAPA&period=max&api_key=YOUR_API_KEY